Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in Multivessel Disease Meta-analysis of Randomized Clinical Trials of the Arterial Grafting and Stenting Era

Sipahi I., Akay M. H. , Dagdelen S. , Blitz A., Alhan C.

JAMA INTERNAL MEDICINE, vol.174, no.2, pp.223-230, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 174 Issue: 2
  • Publication Date: 2014
  • Doi Number: 10.1001/jamainternmed.2013.12844
  • Title of Journal : JAMA INTERNAL MEDICINE
  • Page Numbers: pp.223-230


IMPORTANCE Recent trials of percutaneous coronary intervention (PCI) vs coronary artery bypass grafting (CABG) for multivessel disease were not designed to detect a difference in mortality and therefore were underpowered for this outcome. Consequently, the comparative effects of these 2 revascularization methods on long-term mortality are still unclear. In the absence of solid evidence for mortality difference, PCI is oftentimes preferred over CABG in these patients, given its less invasive nature.